Richard Doubleday, EVP Chief Commercial Officer at DEXCOM INC (DXCM), sold 1,837 shares at $361.46 ($661K) on 2020-12-23, disclosed to the SEC on 2020-12-28.
Seasonal sale ($661k) by EVP Chief Commercial Officer — this insider has traded DXCM in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $357.31 | 120 | $43K | 6.5% |
| 2 | $358.48 | 265 | $95K | 14.4% |
| 3 | $358.48 | 265 | $95K | 14.4% |
| 4 | $359.29 | 282 | $101K | 15.3% |
| 5 | $359.29 | 282 | $101K | 15.3% |
| 6 | $360.62 | 123 |
| $44K |
| 6.7% |
| 7 | $361.46 | 180 | $65K | 9.8% |
| 8 | $361.46 | 180 | $65K | 9.8% |
| 9 | $362.83 | 60 | $22K | 3.3% |
| 10 | $364.15 | 80 | $29K | 4.4% |
| Total | $359.77 avg | 1,837 | $661K | 100% |
| Filing → |
| DXCM | SELL | 2021-01-25 | $815K | — | Filing → |
| DXCM | SELL | 2021-01-06 | $8.1M | — | Filing → |
| DXCM | SELL | 2020-11-25 | $708K | — | Filing → |